Search hospitals > California > Roseville
Kaiser Permanente-Roseville
Claim this profileRoseville, California 95661
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Breast cancer
225 reported clinical trials
9 medical researchers
Summary
Kaiser Permanente-Roseville is a medical facility located in Roseville, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Breast cancer and other specialties. Kaiser Permanente-Roseville is involved with conducting 225 clinical trials across 357 conditions. There are 9 research doctors associated with this hospital, such as Aarati Rao, Jennifer M. Suga, Tatjana Kolevska, MD, and Samantha A. Seaward.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Aarati RaoKaiser Permanente-Oakland5 years of reported clinical research
Expert in Cancer
Expert in Uterine Tumors
60 reported clinical trials
112 drugs studied
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
37 reported clinical trials
102 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo2 years of reported clinical research
Studies Cancer
Studies Skin Cancer
22 reported clinical trials
52 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
22 reported clinical trials
63 drugs studied
Clinical Trials running at Kaiser Permanente-Roseville
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Breast cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Esophageal cancer
Cutaneous Melanoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-Roseville?
Kaiser Permanente-Roseville is a medical facility located in Roseville, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Breast cancer and other specialties. Kaiser Permanente-Roseville is involved with conducting 225 clinical trials across 357 conditions. There are 9 research doctors associated with this hospital, such as Aarati Rao, Jennifer M. Suga, Tatjana Kolevska, MD, and Samantha A. Seaward.